Quick search
Advanced search in
Research outcomes
Field to searchTerm
Add rule
Filters
Filters

COVID-19

Filters

COVID-19

The following results are related to COVID-19. Are you interested to view more results? Visit OpenAIRE - Explore.
Download Results
811 research outcomes, page 1 of 82
  • other research product . 2020
    Open Access English
    Authors:
    Zwickey, Heather;
    Persistent Identifiers

    As the medical community frantically scrambles to address SARS-CoV2, we in the natural community can also be investigating the tools we have that may be helpful during this pandemic. As a scientist who is not a clinician, my opinions come from research, not clinical exp...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    La Scola, Bernard et al.;
    Persistent Identifiers

    In a preliminary clinical study we observed that the combination of hydroxychloroquine and azithromycin was effective active against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount importance to define when a treated patient ...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    D'Adamo, Peter;
    Persistent Identifiers

    Includes: Interferons, Nucleoside analogs, Protease inhibitors, Furin Convertase Cleavage inhibitors, Reverse transcriptase inhibitors, RNA Polymerase/Synthesis Inhibitors, Neuraminidase inhibitors, Angiotensin II receptor blockers, Endosome fusion inhibitors/ Endosome ...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Persistent Identifiers

    This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. Information and data on COVID-19 are rapidly evolving. This guidance includes general information to consider. Clinicians s...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    Vellingiri, Balachandar et al.;
    Persistent Identifiers

    The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc worldwide due to inadequate risk assessment regar...

    Add to ORCID
  • Background: We need an effective treatment to cure COVID-19 patients and to decrease virus carriage duration. Methods: We conducted an uncontrolled, non-comparative, observational study in a cohort of 80 relatively mildly infected inpatients treated with a combination o...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Persistent Identifiers

    Systemic ozone therapy can be “potentially” useful in SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown to be highly effective in research studies. The mechanism of action will be by 1) The ...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    Borges do Nascimento, Israel Júnior et al.;
    Persistent Identifiers

    A growing body of literature on the 2019 novel coronavirus (SARS-CoV-2) is becoming available, but a synthesis of available data has not been conducted. We performed a scoping review of currently available clinical, epidemiological, laboratory, and chest imaging data re...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    Gautret, P, et al. IHU-Méditerranée Infection, Marseille;
    Persistent Identifiers

    Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads. Patients and methods: French Confirmed COVID-19 patients wer...

    Add to ORCID
  • other research product . 2020
    Open Access English
    Authors:
    Andreania, Julien et al.;
    Persistent Identifiers

    Human coronaviruses SARS-CoV-2 appeared at the end of 2019 and led to a pandemic with high morbidity and mortality. As there are currently no effective drugs targeting this virus, drug repurposing represents a short-term strategy to treat millions of infected patients a...

    Add to ORCID
811 research outcomes, page 1 of 82